David Meechan
Impact in
- Reproductive Medicine top 10%
- Ovarian cancer diagnosis and treatment
-
- Pharmaceutical Practices and Patient Outcomes
Papers in
- Oncology 3
- Global Cancer Incidence and Screening 2
- Cancer Risks and Factors 1
-
- Multiple and Secondary Primary Cancers 1
- Co-authors
- Carolynn Gildea (5 shared papers)Greg Rubin (2 shared papers)Thomas Round (1 shared paper)Henrik Møller (1 shared paper)Peter Vedsted (1 shared paper)Mike Richards (1 shared paper)John Butler (2 shared papers)Andy Nordin (2 shared papers)
- Journals
- Journal of Public Health (2 papers)Gynecologic Oncology (2 papers)BMJ (1 paper)British Journal of General Practice (1 paper)Education 3-13 (1 paper)
- Partner nations
- United KingdomDenmarkNorway
In The Last Decade
David Meechan
11 papers receiving 380 citations
Peers
Comparison fields: 5 of 73
- Reproductive Medicine 73
- Geriatrics and Gerontology 19
- Oncology 103
- Family Practice 6
- Obstetrics and Gynecology 17
Countries citing papers authored by David Meechan
This map shows the geographic impact of David Meechan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Meechan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Meechan more than expected).
Fields of papers citing papers by David Meechan
This network shows the impact of papers produced by David Meechan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Meechan. The network helps show where David Meechan may publish in the future.
Co-authors
The 25 scholars most cited alongside David Meechan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 158 | |
| 2 | 2015 | 72 | |
| 3 | 2012 | 63 | |
| 4 | Controlled trial of pharmacist intervention in general practice: the effect on prescribing costs. | 1999 | 33 |
| 5 | 2003 | 20 | |
| 6 | 2014 | 13 | |
| 7 | 2015 | 9 | |
| 8 | Histopathology reporting in cervical screening – an integrated approach | 2012 | 8 |
| 9 | Why does domiciliary oxygen consumption vary from area to area? | 1983 | 5 |
| 10 | Short Term Ovarian Cancer Mortality | 2013 | 3 |
| 11 | 2022 | 1 |
About David Meechan
David Meechan is a scholar working on Oncology, Epidemiology, Reproductive Medicine, Pulmonary and Respiratory Medicine and Health, Toxicology and Mutagenesis, having authored 11 papers that have together received 385 indexed citations. Recurring topics across this work include Global Cancer Incidence and Screening (2 papers), Ovarian cancer diagnosis and treatment (2 papers), Multiple and Secondary Primary Cancers (1 paper), Educational and Psychological Assessments (1 paper), Air Quality and Health Impacts (1 paper), Respiratory Support and Mechanisms (1 paper), Collaborative Teaching and Inclusion (1 paper) and Cancer Risks and Factors (1 paper). The work is most often cited by research in Reproductive Medicine (73 citations), Geriatrics and Gerontology (19 citations), Oncology (103 citations), Family Practice (6 citations) and Obstetrics and Gynecology (17 citations). David Meechan has collaborated with scholars based in United Kingdom, Denmark and Norway. Frequent co-authors include Carolynn Gildea, Greg Rubin, Thomas Round, Henrik Møller, Peter Vedsted, Mike Richards, John Butler, Andy Nordin, Neville F. Hacker and Elizabeth Tracey. Their work appears in journals such as Journal of Public Health, Gynecologic Oncology, BMJ, British Journal of General Practice and Education 3-13.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.